Nov 21 2024
The Georgia Senate Study Committee on Veterans’ Mental Health and Housing has urged state officials to allocate $5 million for research into the use of psychedelic drugs like MDMA and psilocybin as potential treatments for post-traumatic stress disorder (PTSD). The recommendations, presented during Wednesday’s meeting, highlight the growing interest in psychedelics for addressing mental health …
Nov 21 2024
The Oakland City Council has unanimously voted to exempt cannabis from a proposed ordinance that would prohibit smoking in multi-unit residential buildings. The ordinance was approved 6 to 0 through its first reading, with two members abstaining. A final decision is set for December 3. The cannabis exemption was strongly opposed by the state’s anti-smoking …
Nov 21 2024
According to a new study, marijuana-based medicines show promise in treating peripheral neuropathy, a chronic and debilitating condition often resistant to traditional nonsurgical treatments. The study, conducted by researchers from the University of Virginia, explored the potential of cannabis-based medications for managing pain and symptoms associated with peripheral neuropathy, including cases caused by nerve injury, …
Nov 21 2024
Attorney General Ken Paxton has sued the City of Dallas and local officials for adopting a city charter amendment that would “illegally decriminalize marijuana-related offenses and prohibit police from enforcing Texas law.” Earlier this month, the City of Dallas adopted Proposition R, which “prohibits the Dallas Police Department from making arrests or issuing citations for …
Nov 20 2024
A study published in Clinical Parkinsonism & Related Disorders has found that the vast majority of those in France with Parkinson’s disease support medical marijuana and CBD use. In France, cannabis use is illegal outside the current restricted medical cannabis experimental framework which does not include Parkinson’s disease (PD) as an eligible condition. In contrast, …
Nov 20 2024
All parties opposing the rescheduling of marijuana to Schedule 3 of the Controlled Substances Act will have full standing to participate in a landmark marijuana rescheduling hearing, according to a ruling by DEA Chief Administrative Law Judge John Mulrooney II. However, only one organization supporting rescheduling—the National Cannabis Industry Association (NCIA)—has been granted full standing. …
Nov 20 2024
67 members of the U.S. Congress are urging President Joe Biden to build on his record of executive clemency during the final months of his presidency. Representatives Ayanna Pressley (D-MA), Jim Clyburn (D-SC), and Mary Gay Scanlon (D-PA) sent a letter today along with 64 of their colleagues urging President Biden to “reunite families, confront …
Nov 20 2024
The global medical cannabis market is expected to experience rapid growth, with projections showing an increase from $13.12 billion in 2023 to $91.065 billion by 2032. This reflects a compound annual growth rate (CAGR) of 24.02% over the forecast period, according to a new report by Introspective Market Research. This growth is attributed to the …
Nov 20 2024
Researchers are set to launch a groundbreaking clinical trial evaluating the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) among military veterans. The U.S. Food and Drug Administration (FDA) Division of Psychiatry Products has cleared the Multidisciplinary Association for Psychedelic Studies (MAPS)’ Phase 2 study of smoked cannabis in Veterans for the …
Nov 19 2024
In October, legal marijuana states collectively generated $1.872 billion in sales. This total, based on an analysis by The Marijuana Herald, represents a marginal decrease from September’s $1.877 billion, highlighting the market’s stability. Sales data for most states was sourced from their regulatory bodies overseeing the marijuana industry. In instances where this data was unavailable, …
